LYNSEY STONEKING: Open Payments
NPI 1770290256 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,113 in 110 payments from 15 companies in 2025. Trend: 2023 $315 · 2024 $402 · 2025 $2,113
Food & beverage: $2,113
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $422 |
| Novo Nordisk Inc | 17 | $336 |
| ABBVIE INC. | 14 | $219 |
| GlaxoSmithKline, LLC. | 18 | $212 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $199 |
| Amgen Inc. | 15 | $181 |
| Lilly USA, LLC | 5 | $114 |
| Sumitomo Pharma America, Inc. | 5 | $99 |
| Exact Sciences Corporation | 5 | $91 |
| PFIZER INC. | 4 | $82 |
Products named: AIRSUPRA, Ozempic, Kerendia, TRELEGY ELLIPTA, QULIPTA, UBRELVY, GEMTESA, Cologuard Collection Kit.
Industry payments across OK — which companies pay providers there.
